Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. G. Hwang, J. S. Choi, K. H. Seo, Y. H. Kim (Kumi-si, North Kyungbook Province, Chonan, South Choongchung Province, Republic Of Korea). Effect of bronchial artery embolization (BAE) on the management of hemoptysis associated with pulmonary tuberculosis; factors influencing recurrent hemoptysis. Eur Respir J 2008; 32: Suppl. 52, 595

Member's Comments

No comment yet.

Related content which might interest you: Effects of bronchial artery embolization in hemoptysis patients, and factors influencing relapse Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005 Long-term outcome of bronchial artery embolisation (BAE) for massive haemoptysis Source: Annual Congress 2011 - To stent or not to stent: interventional bronchoscopy Year: 2011 Bronchial artery embolisation in the management of haemoptysis in pulmonary tuberculosis Source: Annual Congress 2011 - To stent or not to stent: interventional bronchoscopy Year: 2011 Ttransradial bronchial artery embolization for massive hemoptysis secondary to tuberculosis Source: Virtual Congress 2020 – Imaging evaluation of chronic lung diseases Year: 2020 Role of bronchial artery embolisation in chronic recurrent haemoptysis Source: Annual Congress 2012 - The different ways to establish a diagnosis: needle and forcep Year: 2012 Bronchial artery embolization (BAE) in massive hemoptysis due to chronic inflammatory lung disease. Immediate and long term outcomes Source: Eur Respir J 2005; 26: Suppl. 49, 679s Year: 2005 The role of bronchial artery embolisation in the treatment of hemoptysis Source: Eur Respir J 2005; 26: Suppl. 49, 211s Year: 2005 Role of bronchial artery embolisation in the management of haemoptysis Source: Annual Congress 2008 - Hot and cold techniques Year: 2008 Long term effect of bronchial arterial embolization in hemoptysis patients by pulmonary tuberculosis sequelae Source: Eur Respir J 2006; 28: Suppl. 50, 305s Year: 2006 Characteristics of repeated bronchial artery embolization cases due to recurrent hemoptysis Source: Eur Respir J 2005; 26: Suppl. 49, 679s Year: 2005 Presence of bronchopulmonary shunting is an independent risk factor for recurrence of hemoptysis following bronchial artery embolization in younger patients with bronchiectasis: a long-term outcome Source: International Congress 2019 – Highlights in lung function and chronic cough Year: 2019 Bronchial artery embolization in the treatment of massive hemoptysis Source: Eur Respir J 2006; 28: Suppl. 50, 774s Year: 2006 Outcomes of bronchial artery embolization for the management of hemoptysis Source: Virtual Congress 2021 – Bronchoscopy in the COVID - 19 era: cryobiopsy Year: 2021 Non-bronchial systemic arterial embolization in management of massive hemoptysis secondary to post-tuberculous bronchiectasis in Egypt Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010 Surgical management of severe hemoptysis in the era of bronchial artery embolisation: a series of 111 patients Source: Eur Respir J 2007; 30: Suppl. 51, 582s Year: 2007 Outcomes of bronchial artery embolisation in the management of clinically significant hemoptysis Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Clinical characteristics of bronchial artery embolization in 97 patients with hemoptysis Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017 Year: 2017